MX2022000892A - Metodos para tratar trastornos del sue?o asociados con el dolor. - Google Patents
Metodos para tratar trastornos del sue?o asociados con el dolor.Info
- Publication number
- MX2022000892A MX2022000892A MX2022000892A MX2022000892A MX2022000892A MX 2022000892 A MX2022000892 A MX 2022000892A MX 2022000892 A MX2022000892 A MX 2022000892A MX 2022000892 A MX2022000892 A MX 2022000892A MX 2022000892 A MX2022000892 A MX 2022000892A
- Authority
- MX
- Mexico
- Prior art keywords
- pain
- patient
- sleep disorder
- methods
- sleep
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 title abstract 8
- 208000019116 sleep disease Diseases 0.000 title abstract 8
- 208000020685 sleep-wake disease Diseases 0.000 abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 208000009935 visceral pain Diseases 0.000 abstract 2
- 206010005063 Bladder pain Diseases 0.000 abstract 1
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract 1
- 206010038743 Restlessness Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 230000002618 waking effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962877573P | 2019-07-23 | 2019-07-23 | |
| PCT/US2020/043047 WO2021016338A1 (en) | 2019-07-23 | 2020-07-22 | Methods of treating sleep disorders associated with pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022000892A true MX2022000892A (es) | 2022-03-11 |
Family
ID=72047043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022000892A MX2022000892A (es) | 2019-07-23 | 2020-07-22 | Metodos para tratar trastornos del sue?o asociados con el dolor. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220370468A1 (https=) |
| EP (1) | EP4003357A1 (https=) |
| JP (1) | JP2022541634A (https=) |
| KR (1) | KR20220038344A (https=) |
| CN (1) | CN114144183A (https=) |
| AU (1) | AU2020318996A1 (https=) |
| BR (1) | BR112022001056A2 (https=) |
| CA (1) | CA3147752A1 (https=) |
| MX (1) | MX2022000892A (https=) |
| WO (1) | WO2021016338A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0320637D0 (en) * | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| MX350745B (es) * | 2009-11-06 | 2017-09-14 | Sk Biopharmaceuticals Co Ltd * | El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia. |
| SG11201509989VA (en) * | 2013-06-06 | 2016-01-28 | Astellas Pharma Inc | Benzothiophene compound |
-
2020
- 2020-07-22 EP EP20754465.1A patent/EP4003357A1/en not_active Withdrawn
- 2020-07-22 MX MX2022000892A patent/MX2022000892A/es unknown
- 2020-07-22 AU AU2020318996A patent/AU2020318996A1/en not_active Abandoned
- 2020-07-22 BR BR112022001056A patent/BR112022001056A2/pt not_active IP Right Cessation
- 2020-07-22 WO PCT/US2020/043047 patent/WO2021016338A1/en not_active Ceased
- 2020-07-22 CA CA3147752A patent/CA3147752A1/en active Pending
- 2020-07-22 CN CN202080052544.6A patent/CN114144183A/zh active Pending
- 2020-07-22 US US17/627,993 patent/US20220370468A1/en not_active Abandoned
- 2020-07-22 KR KR1020227001869A patent/KR20220038344A/ko not_active Ceased
- 2020-07-22 JP JP2022504546A patent/JP2022541634A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220038344A (ko) | 2022-03-28 |
| BR112022001056A2 (pt) | 2022-05-24 |
| JP2022541634A (ja) | 2022-09-26 |
| AU2020318996A1 (en) | 2022-02-03 |
| CA3147752A1 (en) | 2021-01-28 |
| CN114144183A (zh) | 2022-03-04 |
| EP4003357A1 (en) | 2022-06-01 |
| WO2021016338A1 (en) | 2021-01-28 |
| US20220370468A1 (en) | 2022-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201992046A1 (ru) | Способ и система для управления стимуляцией головного мозга при помощи биодатчиков | |
| EA201390827A1 (ru) | Применение лаквинимода для уменьшения утомляемости, улучшения функционального состояния и улучшения качества жизни пациентов с рассеянным склерозом | |
| EA202090043A1 (ru) | Диазабициклические замещенные имидазопиримидины и их применение | |
| SG176628A1 (en) | Aminopyrrolidinone derivatives and uses thereof | |
| EA201591290A3 (ru) | Креноланиб для лечения пролиферативных расстройств, связанных с мутацией flt3 | |
| HK1202776A1 (en) | Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy | |
| MY209349A (en) | Methods of treating myeloproliferative disorders | |
| EA200970764A1 (ru) | Способ лечения расстройств, вызванных пролиферацией клеток, с применением стимуляторов секреции гормона роста | |
| MX2022000892A (es) | Metodos para tratar trastornos del sue?o asociados con el dolor. | |
| WO2020084113A8 (en) | Sildenafil for use in the treatment of osteoarthritis | |
| ATE506941T1 (de) | Behandlung psychiatrischer patienten mit schlafstörungen und/oder übermässiger tagesschläfrigkeit mit paliperidon | |
| US20210299080A1 (en) | Method of treatment | |
| EP2724746B1 (en) | System and method for scheduling light therapy | |
| JOP20200046A1 (ar) | طرق لعلاج أمراض مرتبطة بـtnf? | |
| EP1622450A4 (en) | PROCESS FOR PROMOTING UNINTERRUPTED SLEEP BY ADMINISTERING TROPIUM CHLORIDE | |
| RU2020120236A (ru) | Способы применения феноксипропиламиновых соединений для лечения депрессии | |
| Scott | Music and your body: How music affects us and why music therapy promotes health | |
| BR112022000734A2 (pt) | Método para tratar câncer em um paciente, uso de composto 1, e, composto 1 | |
| Honma et al. | Sleep-wake cycles in Humans | |
| RU2648957C1 (ru) | Способ лечения эпилептических спазмов | |
| RU2013137690A (ru) | Способ лечения отсеохондропатии головки бедренной кости | |
| Choi et al. | 0779 Circadian Entrainment in 12h Night Shift Workers: The Environmental Lights Matter? | |
| Sathe | Hypnic jerks treated by clonazepam: case report | |
| Zhang et al. | 0778 Workplace Yoga Program Features and Associations With Shift Work and Sleep Among Nursing Staff | |
| Walters | 27 Opioids and the Restless Legs Syndrome: Treatment and Pathogenetic Considerations |